A California-based biotech company is stealing the show during Wednesday’s premarket after it was announced that the FDA approved Udenyca Onbody, a device used to deliver...

To read the full story on AllPennyStocks.com, click here.

Coherus BioSciences (NASDAQ:CHRS)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024 Plus de graphiques de la Bourse Coherus BioSciences
Coherus BioSciences (NASDAQ:CHRS)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024 Plus de graphiques de la Bourse Coherus BioSciences